The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zabolotskikh I.B.

Kuban State Medical University

Bautin A.E.

North-West Federal Medical Research Center named after V.A. Almazov

Bayalieva A.Zh.

Kazan State Medical University

Grigoriev S.V.

Kuban State Medical University

Zamyatin M.N.

National Medical and Surgical Center named after N.I. Pirogov

Kirov M.Yu.

Northern State Medical University

Lebedinskii K.M.

North-Western State Medical University n.a. Mechnikov, Federal Research;
Clinical Center of Intensive Care Medicine and Rehabilitology

Perioperative management of patients with valvular heart disease

Authors:

Zabolotskikh I.B., Bautin A.E., Bayalieva A.Zh., Grigoriev S.V., Zamyatin M.N., Kirov M.Yu., Lebedinskii K.M.

More about the authors

Read: 34499 times


To cite this article:

Zabolotskikh IB, Bautin AE, Bayalieva AZh, Grigoriev SV, Zamyatin MN, Kirov MYu, Lebedinskii KM. Perioperative management of patients with valvular heart disease. Russian Journal of Anesthesiology and Reanimatology. 2020;(4):6‑31. (In Russ.)
https://doi.org/10.17116/anaesthesiology20200416

Recommended articles:
Features of perioperative period in patients with cardiovascular-kidney-metabolic syndrome. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):26-33
Influence of menstrual phase on the effect of rocu­ronium bromide. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):14-18
Open-access data­bases in anesthesiology and inte­nsive care: a systematic review and guidelines. Russian Journal of Anesthesiology and Reanimatology. 2025;(4):61-71
What we have to change in the treatment of ST-segment elevation myocardial infa­rction?. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):183-190
Surgical treatment of patients with functional mitral regu­rgitation and aortic valve disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):310-325
Mice and rats wound infe­ction models for testing new drugs under deve­lopment. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(3):9-24
Meta-analysis on the rele­vance of septal myectomy in aortic valve replacement. Piro­gov Russian Journal of Surgery. 2025;(10-2):94-99

References:

  1. Baumgartner H, Falk V, Bax J, De Bonis M, et al. Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017. https://doi.org/10.1093/eurheartj/ehx391
  2. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Lüscher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Sousa-Uva M, Voudris V, Funck-Brentano C; Authors/Task Force Members. Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383-2431.
  3. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. Am J Cardiol. 1997;29:33:630-634. 
  4. Goldbarg SH, Elmariah S, Miller M, Fuster V. Insights Into Degenerative Aortic Valve Disease. J Am Coll Cardiol. 2007;50:13:1205-1213.
  5. Reid CL, Anton-Culver H, Yunis C, Gardin JM. Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol. 2007;99:6:830-834. 
  6. Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. J Can Cardiol. 2014;30:9:962-970. 
  7. Chikwe J, Walther A, Pepper J. The Surgical Management of Mitral Valve Disease. Br J Cardiol. 2004;11(1):42-48. 
  8. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:13:1231-1243.
  9. Bokeria LA. Clinical recommendations for the management, diagnosis and treatment of valvular heart diseases. M.: Publishing House NTSSSH im. A.N. Bakuleva RAMS; 2009. (In Russ).
  10. Pacher R, Maurer G, Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109:2302-2308.
  11. Selzer A, Cohn KE. Natural history of mitral stenosis: a review. Circulation. 1972;45:878-890. 
  12. Tarasoutchi F, Grinberg M, Spina GS et al. Ten-year clinical, laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation ofpredominant rheumatic etiology. J Am CollCardiol. 2003;41:1316-1324.
  13. Herrera A. Valvular Heart Disease. Stoelting’s Anesthesia and Co-Existing Disease. 6th ed. [edited by] Roberta L. Hines, Katherine E. Marschall. Saunders. 2012.
  14. Goffinet C, Kersten V, Pouleur AC, Le Polain de Waroux JB, Vancraeynest D, Pasquet A, Vanoverschelde JL, Gelber BL. Comprehensive assessment of the severity and mechanism of aortic regurgitation using multidetector CT and MR. Eur Radiol. 2010;20:326-336. 
  15. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95:2262-2270.
  16. Dubin AA, March HW, Cohn K, Selzer A. Longitudinal hemodynamicand clinical study of mitral stenosis. Circulation. 1971;44:381-389. 
  17. Munt B, Legget ME, Kraft CD, Miyake-Hull CY, Fujioka M,Otto CM. Physical examination in valvular aortic stenosis: correlationwith stenosis severity and prediction of clinical outcome. Am Heart J. 1999;137:298-306. 
  18. Parker E, Craige E, Hood WP Jr. The Austin Flint murmur and thea wave of the apexcardiogram in aortic regurgitation. Circulation. 1971;43:349-359. 290. Fortuin NJ, Craige E. On the mechanism of the Austin Flintmurmur. Circulation. 1972;45:558-560. 
  19. Das P, Rimington H, Chambers J. Exercise testing to stratify risk inaortic stenosis. Eur Heart J. 2005;26:1309-1313.
  20. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, BudajAet al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
  21. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H. et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999-3054.
  22. Steg PG, James SK, Atar D, Badano LP, Blo¨mstrom-Lundqvist C, Borger MA et al.ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569-2619.
  23. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67-119. 
  24. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33:2451-2496.
  25. Ponikowski P, Voors AA, Anker SD, et al. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200.  https://doi.org/10.1093/eurheartj/ehw128
  26. Myasnikova VV, Karakhalis NB, Musaeva TS, Zabolotskikh IB. Perioperative management of patients with tachyarrhythmias in non-cardiac surgery. Intensive care herald. 2017;1:37-55. (In Russ.).
  27. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Russ J Cardiol. 2016;7(135):5-86. (In Russ.). https://doi.org/10.15829/1560-4071-2016-7-5-86
  28. Landoni G, Fochi O, Bignami E, et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A metaanalysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1:34-43. 
  29. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of ardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64(22):77-137.  https://doi.org/10.1016/j.jacc.2014.07.944
  30. Guay J, Choi P, Suresh S, et al. Neuraxial blockade for the prevention of post-operative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2014;1:CD010108.
  31. Rodgers A, Walker N, Schug S, et al. Reduction of post-operative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000;321:1493-1497.
  32. Frasco PE, De Bruijn NP. Cardiac Anesthesia: Principles and Practice. 2002.
  33. Mueller H, Chatterjee K, Davis K, et al. Present use of bedside right heart catheterization in patients with cardiac disease. JACC. 1998;32(3):840-864. 
  34. American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology. 2010;112(5):1084‐1096. https://doi.org/10.1097/ALN.0b013e3181c51e90
  35. Bautin AE, Osovskikh VV, Basova VA. Echocardiographic monitoring. In book: Blood circulation and anesthesia. Ed. Lebedinskii K.M. SPb.: Man; 2012. (In Russ.).
  36. Pöpping DM, Elia N, Van Aken HK, et al. Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials. Ann Surg. 2014;259(6):1056-1067. https://doi.org/10.1097/SLA.0000000000000237
  37. Nishimori M, Low JHS, Zheng H, et al. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev. 2012;7:CD005059.
  38. Tashiro T, Pislaru SV, Blustin JM, Nkomo VT, Abel MD, Scott CG, Pellikka PA. Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice. Eur Heart J. 2014;35(35):2372-2381.
  39. Trekova NA i dr. Anesthesia in cardiovascular surgery. In the book. Anesthesiology. A national guide. Edited by Bunyatyan A.A., Mizikova V.M. M.: GEOTAR-Media; 2011. (In Russ.).
  40. Hansley FA Jr, Martin DE, Gravelly GP. Per English under the editorship of Bunatyan A.A.; trans. Khomenko E.A., Nikitin A.A., Tsiklinsky S.A., Dyachkov A.N. Practical Cardioanesthesiology. 5th ed. M.: Publishing House Medical Information Agency LLC; 2017. (In Russ.).
  41. Kossman ChE, et al. The Criteria Committee of the New York Heart Association. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. 6th ed. Boston, MA: Little Brown; 1964.
  42. Wong, Christopher J, Hamlin, Nason P. The Medicine Consult Handbook. Seattle: University of Washington Medical Center; 2013-2318.
  43. Nussmeier NA, et al. Анестезия при кардиохирургических операциях. В кн.: «Анестезия» Рональда Миллера. Под ред. Миллера Р. Пер. с англ. под общей ред. Лебединского К.М. В 4 т. СПб.: Человек; 2015.
  44. Herrera A. Valvular Heart Disease. Hines & Marschall: Stoelting’s Anesthesia and Co-Existing Disease, 5th ed. Churchill Livingstone. 2008;676. 
  45. Morgan JE, Mikhail MS. Clinical anesthesiology. Ed. 4th. M.: Binom; 2017. (In Russ.).
  46. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;52:1-142. 
  47. Zabolotskikh IB, Kirov MYu, Afonchikov VS, Bulanov AYu, Grigoryev EV, Gritsan AI, Zamyatin MN, Kurapeev IS, Lebedinskii KM, Lomivorotov VV, Lubnin AYu, Ovechkin AM, Potievskaya VI, Roitman EV, Sinkov SV, Subbotin VV, Shulutko EM. Perioperative management of patients receiving long-term antithrombotic therapy. Russian Federation of anesthesiologists and reanimatologists guidelines. Annals of critical care. 2019;1:7-19. (In Russ.). https://doi.org/10.21320/1818-474X-2019-1-7-19
  48. Pernod G, Godier A, Gozalo C, et al. French National Authority for Health. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). Thromb Res. 2010;126:167-174. 
  49. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL.; 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;29(19): pii: ehv319.
  50. Roizen MF, Fleisher LA. In: Miller RD, ed. Anesthetic implication of concurred diseases in Miller’s anesthetic. 6th ed. Chapter 27. Elsevier, 2005.
  51. Camm AJ, Lip GY, De Caterina R, et al. 2012 focussed update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-2747.
  52. European Society of Cardiology (European Society of Anaesthesilogy). 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management. Russian Journal of Cardiology. 2015;8:7-66. (In Russ.). https://doi.org/10.15829/1560-4071-2015-8-7-66
  53. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group (erratum appears in Circulation 2007;116:376-377). Circulation. 2007;116:1736-1754.
  54. Roizen, MF. Anesthestic Implications of Comorbid Diseases. Chapter 35. In: Miller’s Anesthesia. 7th Edition, Churchill Livingstone, 2009.
  55. Rosengart TK, et al. Percutaneous and Minimally Invasive Valve Procedures. A Scientific Statement From the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2008;117:1750-1767.
  56. Messika-Zeitoun D, Serfaty JM, Laissy JP, et al. Assessment of mitral valve area in patients with mitral stenosis by multislice computed tomography. J Am Coll Cardiol. 2006;48:411-413. 
  57. Nishimura RA, Carabello BA, Faxon DP, Freed MD, Lytle BW, O’Gara PT, O’Rourke RA, Shah PM. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;52:676-685. 
  58. Rahimtoola SH. The Year in Valvular Heart Disease. J Am Coll Cardiol. 2008;51:760-770. 
  59. Cardiology. National leadership. Ed. Belenkov Yu.N., Oganov R.G. M.: GEOTAR-Media; 2008. (In Russ.).
  60. Blood circulation and anesthesia. Evaluation and correction of systemic hemodynamics during surgery and anesthesia. Ed. Prof. Lebedinskii K.M. 2nd ed. SPb.: Man; 2015. (In Russ.).
  61. Allman C, Wilson A. Oxford Handbook of Anesthesia. Per. from English M.: Binom TD; 2009. (In Russ.).
  62. Diseases of the endocardium, myocardium and pericardium. In the book: Cardiology. A national guide: a short edition. Ed. Belenkov Yu.N., Oganov R.G. M.: GEOTAR-Media; 2012. (In Russ.).
  63. Anaesthesia for the high risk patient. Ed.: McConachie I. Greenwich Medical Media Limited. 2002;265. 
  64. Butchart EG, Gohlke-Barwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B, Prendergast B, Iung B, Bjornstad H, Leport C, Hall RJC, Vahanian A. Recommendations for the management of patients after heart valve surgery. European Heart Journal. 2005;26:2463-2471.
  65. De Hert S, Imberger G, Carlisle J, Diemunsch P, Fritsch G, Moppett I, Solca M, Staender S, Wappler F, Smith A. Task Force on Preoperative Evaluation of the Adult Noncardiac Surgery Patient of the European Society of Anaesthesiology. Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011;28(10):684-722. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.